Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled st (Q43153951)
Jump to navigation
Jump to search
scientific article published on 23 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled st |
scientific article published on 23 February 2010 |
Statements
1 reference
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled st (English)
1 reference
Nizar El-Khalili
1 reference
Mark Joyce
1 reference
Sarah Atkinson
1 reference
Robert J Buynak
1 reference
Catherine Datto
1 reference
Petter Lindgren
1 reference
Hans Eriksson
1 reference
23 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference